908 Devices Inc. (MASS) stock
MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/3041% above fair value
$9.52+0.13 (+1.38%)
Close on Nov 18, 2026Market cap $393.50MP/E –Yield –
908 Devices revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
908 Devices's revenue for the twelve months ending Jun 30, 2026 was $60.84M, up 13.4% year over year. For fiscal 2025 it was $56.20M, up 17.7% from the year before. The highest annual figure on record is $56.20M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.20M | +17.7% |
| FY2024 | Dec 31, 2024 | $47.75M | -4.9% |
| FY2023 | Dec 31, 2023 | $50.23M | +7.2% |
| FY2022 | Dec 31, 2022 | $46.85M | +11.0% |
| FY2021 | Dec 31, 2021 | $42.21M | +56.9% |
| FY2020 | Dec 31, 2020 | $26.89M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $16.07M | +23.3% |
| Q1 FY2026 | Mar 31, 2026 | $13.38M | +13.6% |
| Q4 FY2025 | Dec 31, 2025 | $17.38M | +21.2% |
| Q3 FY2025 | Sep 30, 2025 | $14.01M | -3.5% |
| Q2 FY2025 | Jun 30, 2025 | $13.04M | +13.7% |
| Q1 FY2025 | Mar 31, 2025 | $11.78M | +58.7% |
| Q4 FY2024 | Dec 31, 2024 | $14.34M | -0.1% |
| Q3 FY2024 | Sep 30, 2024 | $14.52M | +1.6% |
| Q2 FY2024 | Jun 30, 2024 | $11.46M | -5.2% |
| Q1 FY2024 | Mar 31, 2024 | $7.42M | -21.8% |
| Q4 FY2023 | Dec 31, 2023 | $14.35M | +23.3% |
| Q3 FY2023 | Sep 30, 2023 | $14.30M | -9.5% |
| Q2 FY2023 | Jun 30, 2023 | $12.09M | +8.9% |
| Q1 FY2023 | Mar 31, 2023 | $9.49M | +14.2% |
| Q4 FY2022 | Dec 31, 2022 | $11.64M | -26.5% |
| Q3 FY2022 | Sep 30, 2022 | $15.80M | +25.9% |
| Q2 FY2022 | Jun 30, 2022 | $11.11M | +34.2% |
| Q1 FY2022 | Mar 31, 2022 | $8.31M | +49.8% |
| Q4 FY2021 | Dec 31, 2021 | $15.84M | +177.1% |
| Q3 FY2021 | Sep 30, 2021 | $12.55M | +107.4% |
| Q2 FY2021 | Jun 30, 2021 | $8.28M | -25.6% |
| Q1 FY2021 | Mar 31, 2021 | $5.54M | +38.5% |
| Q4 FY2020 | Dec 31, 2020 | $5.72M | – |
| Q3 FY2020 | Sep 30, 2020 | $6.05M | – |
| Q2 FY2020 | Jun 30, 2020 | $11.13M | – |
| Q1 FY2020 | Mar 31, 2020 | $4.00M | – |
See a number that looks wrong?